Leukemia & Lymphoma, Volume 64, Issue 8 (2023)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 64, Issue 8 (2023)

See all volumes and issues
Vol 65, 2024 Volume 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs Download issue

Commentaries

CAR T-cells in MCL: mind the gap
Adrian Minson & Michael Dickinson
Pages: 1359-1360
Published online: 10 Jun 2023
CitationforCAR T-cells in MCL: mind the gap | Full Text | References | PDF (255.2 KB) | EPUB
  • 103 Views
  • 0 CrossRef citations
  • 0Altmetric

Reviews

Review Article
Understanding high-risk smoldering multiple myeloma
Natalia Kreiniz & Morie A. Gertz
Pages: 1361-1372
Published online: 25 May 2023
AbstractforUnderstanding high-risk smoldering multiple myeloma | Full Text | References | PDF (1.3 MB) | EPUB
  • 399 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Pathogenesis, clinical characteristics and personalized managements of multiple myeloma with chromosome 1 abnormalities
Pan Zhou, Weiya Li, Suqiong Zuo, Rongjun Ma, Xiaoli Yuan & Zunmin Zhu
Pages: 1373-1388
Published online: 10 Jun 2023
AbstractforPathogenesis, clinical characteristics and personalized managements of multiple myeloma with chromosome 1 abnormalities | Full Text | References | PDF (1 MB) | EPUB
  • 184 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Clonal evolution in aplastic anemia: failed tumor surveillance or maladaptive recovery?
Carmelo Gurnari, Simona Pagliuca & Jaroslaw P. Maciejewski
Pages: 1389-1399
Published online: 25 Jun 2023
AbstractforClonal evolution in aplastic anemia: failed tumor surveillance or maladaptive recovery? | Full Text | References | PDF (1.1 MB) | EPUB
  • 424 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Role of interleukins in acute myeloid leukemia
Yin Wang, Xiao Tang, Yu Zhu, Xiao-xiao Yang & Bei Liu
Pages: 1400-1413
Published online: 01 Jun 2023
AbstractforRole of interleukins in acute myeloid leukemia | Full Text | References | PDF (1.2 MB) | EPUB
  • 238 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Articles

Article
Exploring new prognostic biomarkers in Mantle Cell Lymphoma: a comparison of the circSCORE and the MCL35 score
Ruth Salim, Simon Husby, Christian Winther Eskelund, David W. Scott, Harald Holte, Arne Kolstad, Riikka Räty, Sara Ek, Mats Jerkeman, Christian Geisler, Lasse Sommer Kristensen, Mette Dahl & Kirsten Grønbæk
Pages: 1414-1423
Published online: 01 Jun 2023
AbstractforExploring new prognostic biomarkers in Mantle Cell Lymphoma: a comparison of the circSCORE and the MCL35 score | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 148 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Brentuximab-vedotin in combination with cyclophosphamide, doxorubicin, prednisolone for the treatment of aggressive CD30-positive cutaneous T-cell lymphomas
Emmanuel Ribereau-Gayon, Marie Donzel, Felix Pham, Nicolas Romain-Scelle, Marie Perier-Muzet, Brigitte Balme, Alexandra Traverse-Glehen, Hervé Ghesquières & Stéphane Dalle
Pages: 1424-1432
Published online: 31 May 2023
AbstractforBrentuximab-vedotin in combination with cyclophosphamide, doxorubicin, prednisolone for the treatment of aggressive CD30-positive cutaneous T-cell lymphomas | Full Text | References | PDF (718.5 KB) | EPUB | Supplemental
  • 257 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Ki67 proliferation index in follicular lymphoma is associated with favorable outcome in patients treated with R-CHOP
Meredith M. Nichols, Sarah L. Ondrejka, Sujata Patil, Lisa Durkin, Brian T. Hill & Eric D. Hsi
Pages: 1433-1441
Published online: 24 May 2023
AbstractforKi67 proliferation index in follicular lymphoma is associated with favorable outcome in patients treated with R-CHOP | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 289 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Cost-Effectiveness of brexucabtagene autoleucel for relapsed/refractory mantle cell lymphoma
M. Marchetti & C. Visco
Pages: 1442-1450
Published online: 25 May 2023
AbstractforCost-Effectiveness of brexucabtagene autoleucel for relapsed/refractory mantle cell lymphoma | Full Text | References | PDF (984.2 KB) | EPUB
  • 1139 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Increased mortality in patients with hematologic malignancies treated with proton pump inhibitors: a nationwide cohort study
Adam Vilmar, Christian Dehlendorff, Søren Friis, Marja Jäättelä, Siri Tvingsholm & Henrik Frederiksen
Pages: 1451-1457
Published online: 09 Jun 2023
AbstractforIncreased mortality in patients with hematologic malignancies treated with proton pump inhibitors: a nationwide cohort study | Full Text | References | PDF (739.1 KB) | EPUB
  • 167 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Evaluation of physician guideline adherence and areas for improvement in managing patients with chronic myeloid leukemia: a cross-sectional survey
Hong Chen, Yuming Zhang, Yirong Jiang, LiE Lin, Shuqin Cheng, Xiaojun Xu, Xiong Zhang, Haiqing Lin, Zhenqian Huang, Qiang Wang, Xuan Zhou, Hong Qu, Xiaoli Liu, Weiming Li & Na Xu
Pages: 1458-1464
Published online: 06 Jun 2023
AbstractforEvaluation of physician guideline adherence and areas for improvement in managing patients with chronic myeloid leukemia: a cross-sectional survey | Full Text | References | PDF (784.3 KB) | EPUB | Supplemental
  • 172 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Impact of timing of stem cell return following high dose melphalan in multiple myeloma patients with renal impairment: a single center experience
George Nesr, Raakhee Shah, Charalampia Kyriakou, Jonathan Sive, Rakesh Popat, Kwee Yong, Brendan Wisniowski, Ke Xu, Ashu Wechalekar, Lydia Lee, Stuart Ings, Xenofon Papanikolaou, Shameem Mahmood, Annabel Mcmillan, Jackie Horder, Fiona Newrick, Jotham Marfil, Louise Ainley, Samir Asher, Simon Cheesman & Neil Rabin
Pages: 1465-1471
Published online: 01 Jun 2023
AbstractforImpact of timing of stem cell return following high dose melphalan in multiple myeloma patients with renal impairment: a single center experience | Full Text | References | PDF (678.3 KB) | EPUB | Supplemental
  • 786 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Letters to the Editor

A retrospective single-center analysis of CD-19 directed CAR T-cell therapy in relapsed/refractory mantle cell lymphoma
Titas Banerjee, Matthew Newman, Andy Chen, Richard T. Maziarz, Levanto Schachter, Stephen E. Spurgeon & Anusha Vallurupalli
Pages: 1472-1475
Published online: 07 Jun 2023
First Page PreviewforA retrospective single-center analysis of CD-19 directed CAR T-cell therapy in relapsed/refractory mantle cell lymphoma | Full Text | References | PDF (496.1 KB) | EPUB
  • 168 Views
  • 0 CrossRef citations
  • 0Altmetric
Time to first transfusion in lower-risk patients with myelodysplastic neoplasia (MDS) is another prognostic factor of survival
Hans Tilman Steinmetz, J. Toczek-Thiel, J. Lipke, R. Liersch, A. Sauer, H. Tesch, J. Heßling, U. Totzke & S. Schmitz
Pages: 1476-1479
Published online: 31 May 2023
First Page PreviewforTime to first transfusion in lower-risk patients with myelodysplastic neoplasia (MDS) is another prognostic factor of survival | Full Text | References | PDF (493.2 KB) | EPUB | Supplemental
  • 88 Views
  • 0 CrossRef citations
  • 0Altmetric
Post PARP inhibitor therapy-related acute megakaryoblastic leukemia in a patient with germline BRCA1-mutated high-grade serous ovarian carcinoma
Hamza Tariq & Sindhu Shetty
Pages: 1480-1484
Published online: 19 May 2023
First Page PreviewforPost PARP inhibitor therapy-related acute megakaryoblastic leukemia in a patient with germline BRCA1-mutated high-grade serous ovarian carcinoma | Full Text | References | PDF (845.9 KB) | EPUB
  • 116 Views
  • 0 CrossRef citations
  • 0Altmetric
Successful management of central nervous system manifestations of chronic graft-vs-host disease: a case report
Ronak Kundalia, Anas Hanini, Syeda Saba Kareem, Rebecca Gonzalez, Tyra Gatewood, Asmita Mishra, Yolanda Pina & Sepideh Mokhtari
Pages: 1485-1489
Published online: 16 Jun 2023
First Page PreviewforSuccessful management of central nervous system manifestations of chronic graft-vs-host disease: a case report | Full Text | References | PDF (789.9 KB) | EPUB
  • 219 Views
  • 0 CrossRef citations
  • 0Altmetric
Central nervous system involvement (Bing-Neel Syndrome) in patients with Waldenström macroglobulinemia
Saurabh Zanwar, Jithma P. Abeykoon, Stephen M. Ansell, Morie A. Gertz, Michelle Mauermann, Thomas E. Witzig, Patrick Johnston, Robert A. Kyle, Rebecca L. King, Thomas M. Habermann, Shaji Kumar & Prashant Kapoor
Pages: 1490-1493
Published online: 10 Jun 2023
First Page PreviewforCentral nervous system involvement (Bing-Neel Syndrome) in patients with Waldenström macroglobulinemia | Full Text | References | PDF (681.4 KB) | EPUB | Supplemental
  • 310 Views
  • 0 CrossRef citations
  • 0Altmetric
Miliary leukemia cutis as extramedullary relapse of KMT2A rearranged pediatric AML
E. Muratore, T. Belotti, F. Gottardi, C. Sagramoso, A. Prete & R. Masetti
Pages: 1494-1496
Published online: 23 May 2023
First Page PreviewforMiliary leukemia cutis as extramedullary relapse of KMT2A rearranged pediatric AML | Full Text | References | PDF (737.7 KB) | EPUB
  • 89 Views
  • 0 CrossRef citations
  • 0Altmetric
Apoptotic colitis secondary to Brentuximab Vedotin: an immune mediated adverse event responsive to steroid treatment
Maria Vittoria Dubbini, Loredana De Marco, Licia Baldi, Luana Vignolo & Fiorella Ilariucci
Pages: 1497-1499
Published online: 06 Jun 2023
First Page PreviewforApoptotic colitis secondary to Brentuximab Vedotin: an immune mediated adverse event responsive to steroid treatment | Full Text | References | PDF (737.4 KB) | EPUB
  • 137 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia
Jennifer Marvin-Peek et al.
Article | Published online: 15 May 2024
Mitigating time toxicity in lymphoma and multiple myeloma
Mengyang Di et al.
Review Article | Published online: 15 May 2024
Pharmacokinetics of idelalisib in chronic lymphocytic leukemia and follicular lymphoma disclose better outcomes for patients with lower exposure
Fabien Despas et al.
Letter to the Editor | Published online: 15 May 2024
Prevalence and clinicopathological features of incidentally detected TRBC1-dim populations in peripheral blood flow cytometry
Paul Wadsworth et al.
Letter to the Editor | Published online: 15 May 2024
View all latest articles